186 related articles for article (PubMed ID: 30464413)
1. The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.
Jiao H; Ren H
Drug Des Devel Ther; 2018; 12():3817-3824. PubMed ID: 30464413
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline.
Zhang ZY; Zhang Z; Fauser U; Schluesener HJ
J Cell Mol Med; 2009 Feb; 13(2):341-51. PubMed ID: 18400050
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effects of ginkgolides in Guillain-Barré syndrome and experimental autoimmune neuritis.
Li C; Liu S; Aerqin Q; Shen D; Wu X; Liu K
J Clin Neurosci; 2021 May; 87():44-49. PubMed ID: 33863532
[TBL] [Abstract][Full Text] [Related]
4. Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses.
Xiao J; Zhai H; Yao Y; Wang C; Jiang W; Zhang C; Simard AR; Zhang R; Hao J
Neuroscience; 2014 Mar; 262():156-64. PubMed ID: 24412705
[TBL] [Abstract][Full Text] [Related]
5. The dynamic expression of canonical Wnt/β-catenin signalling pathway in the pathologic process of experimental autoimmune neuritis.
Liu Y; Liu S; Pan S; Gong Q; Yao J; Lu Z
Int J Neurosci; 2020 Nov; 130(11):1109-1117. PubMed ID: 32009498
[No Abstract] [Full Text] [Related]
6. Siponimod ameliorates experimental autoimmune neuritis.
Uchi T; Konno S; Kihara H; Fujioka T
J Neuroinflammation; 2023 Feb; 20(1):35. PubMed ID: 36788526
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
[TBL] [Abstract][Full Text] [Related]
9. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
Taylor JM; Pollard JD
Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
[TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Zhu J
J Neuroimmunol; 2003 Jul; 140(1-2):97-101. PubMed ID: 12864976
[TBL] [Abstract][Full Text] [Related]
12. Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
Jin T; Yu H; Wang D; Zhang H; Zhang B; Quezada HC; Zhu J; Zhu W
Immunol Lett; 2016 Mar; 171():15-25. PubMed ID: 26791957
[TBL] [Abstract][Full Text] [Related]
13. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy.
Moalem-Taylor G; Allbutt HN; Iordanova MD; Tracey DJ
Brain Behav Immun; 2007 Jul; 21(5):699-710. PubMed ID: 17005365
[TBL] [Abstract][Full Text] [Related]
14. P2X7 receptor antagonists modulate experimental autoimmune neuritis via regulation of NLRP3 inflammasome activation and Th17 and Th1 cell differentiation.
Xie Y; Han R; Li Y; Li W; Zhang S; Wu Y; Zhao Y; Liu R; Wu J; Jiang W; Chen X
J Neuroinflammation; 2024 Mar; 21(1):73. PubMed ID: 38528529
[TBL] [Abstract][Full Text] [Related]
15. Curcumin ameliorates rat experimental autoimmune neuritis.
Han F; Luo B; Shi R; Han C; Zhang Z; Xiong J; Jiang M; Zhang Z
J Neurosci Res; 2014 Jun; 92(6):743-50. PubMed ID: 24482305
[TBL] [Abstract][Full Text] [Related]
16. AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Zug C; Nuesslein-Hildesheim B; Leppert D; Schluesener HJ
J Neuroimmunol; 2009 Nov; 216(1-2):59-65. PubMed ID: 19804913
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.
Langert KA; Goshu B; Stubbs EB
J Neurochem; 2017 Jan; 140(2):334-346. PubMed ID: 27861905
[TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
[TBL] [Abstract][Full Text] [Related]
19. FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.
Kremer L; Taleb O; Boehm N; Mensah-Nyagan AG; Trifilieff E; de Seze J; Brun S
J Neuroinflammation; 2019 Mar; 16(1):54. PubMed ID: 30825874
[TBL] [Abstract][Full Text] [Related]
20. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
Lonigro A; Devaux JJ
Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
